AU7467094A - Method of diagnosing alzheimer's disease - Google Patents
Method of diagnosing alzheimer's diseaseInfo
- Publication number
- AU7467094A AU7467094A AU74670/94A AU7467094A AU7467094A AU 7467094 A AU7467094 A AU 7467094A AU 74670/94 A AU74670/94 A AU 74670/94A AU 7467094 A AU7467094 A AU 7467094A AU 7467094 A AU7467094 A AU 7467094A
- Authority
- AU
- Australia
- Prior art keywords
- disease
- diagnosing alzheimer
- alzheimer
- diagnosing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20344993 | 1993-08-17 | ||
| JP5-203449 | 1993-08-17 | ||
| PCT/JP1994/001359 WO1995005395A1 (en) | 1993-08-17 | 1994-08-17 | Method of diagnosing alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7467094A true AU7467094A (en) | 1995-03-14 |
Family
ID=16474309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU74670/94A Abandoned AU7467094A (en) | 1993-08-17 | 1994-08-17 | Method of diagnosing alzheimer's disease |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7467094A (en) |
| WO (1) | WO1995005395A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0859642A2 (en) * | 1995-10-17 | 1998-08-26 | G.D. Searle & Co. | Method of detecting cyclooxygenase-2 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839283A (en) * | 1986-12-30 | 1989-06-13 | Zymogenetics, Inc. | Method of expressing alpha-1-antitrypsin in yeast |
| JP2815461B2 (en) * | 1990-05-09 | 1998-10-27 | 武田薬品工業株式会社 | Neurotrophic activity inhibitor |
| US5473051A (en) * | 1990-07-19 | 1995-12-05 | The Scripps Research Institute | Inhibition of Mac-1 receptor binding to fibrinogen using D30 homologs |
-
1994
- 1994-08-17 WO PCT/JP1994/001359 patent/WO1995005395A1/en not_active Ceased
- 1994-08-17 AU AU74670/94A patent/AU7467094A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995005395A1 (en) | 1995-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2414092A (en) | Diagnostic method for alzheimer's disease | |
| ZA9410095B (en) | Methods of inhibiting Alzheimer's Disease | |
| AU2765992A (en) | Method for screening for alzheimer's disease | |
| EP0773797A4 (en) | A method of diagnosing alzheimer's disease | |
| IL105216A0 (en) | Method and kit for the diagnosis of alzheimer's disease | |
| GB9316727D0 (en) | Models of alzheimers's disease | |
| AU5508798A (en) | Diagnostic and therapeutic reagents for alzheimer's disease | |
| AU8392291A (en) | Tachykinin agonists for treatment of alzheimer's disease | |
| AU1407399A (en) | Treatment for alzheimer's disease | |
| AU7556994A (en) | Methods for the diagnosis of alzheimer's disease | |
| AU7397094A (en) | Prevention and treatment of alzheimer's disease | |
| AU7708498A (en) | Nematode model for alzheimer's disease | |
| AU6268694A (en) | Swimmer's aid | |
| AU1189395A (en) | Apolipoprotein e polymorphism and alzheimer's disease | |
| AU5857296A (en) | Use of leukotriene antagonists for alzheimer's disease | |
| AU4636993A (en) | Diagnosing alzheimer's disease and schizophrenia | |
| AUPN649395A0 (en) | A method for diagnosing alzheimer's disease | |
| AU5053296A (en) | Pharmaceutical agents for the treatment of Alzheimer's disease | |
| AU5880596A (en) | Methods and compounds for diagnosing coronary artery disease | |
| AU9017098A (en) | Method for diagnosing alzheimer's disease | |
| AU4012795A (en) | Alzheimer's peptide | |
| AU7201696A (en) | Method of diagnosing crohn's disease | |
| AU7467094A (en) | Method of diagnosing alzheimer's disease | |
| AU1072195A (en) | Diagnosis of alzheimer's disease | |
| AU2990692A (en) | Diagnostic method for pompe's disease |